Compile Data Set for Download or QSAR
Report error Found 272 Enz. Inhib. hit(s) with all data for entry = 8473
TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251623(US9453031, 46)
Affinity DataIC50: 38nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251621(US9453031, 44)
Affinity DataIC50: 44nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251635(US9453031, 72)
Affinity DataIC50: 45.3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251641(US9453031, 78)
Affinity DataIC50: 47nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251622(US9453031, 45)
Affinity DataIC50: 53nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251652(US9453031, 103)
Affinity DataIC50: 58nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251638(US9453031, 75)
Affinity DataIC50: 93nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251634(US9453031, 71)
Affinity DataIC50: 99.3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251651(US9453031, 102)
Affinity DataIC50: 100nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#90-0083), which is a homogeneous assay to m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251647(US9453031, 93)
Affinity DataIC50: 117nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251578(US9453031, 1)
Affinity DataIC50: 146nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251630(US9453031, 67)
Affinity DataIC50: 151nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251637(US9453031, 74)
Affinity DataIC50: 152nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251582(US9453031, 5)
Affinity DataIC50: 194nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251627(US9453031, 64)
Affinity DataIC50: 196nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#90-0083), which is a homogeneous assay to m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251662(US9453031, 87)
Affinity DataIC50: 210nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#90-0083), which is a homogeneous assay to m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251656(US9453031, 109)
Affinity DataIC50: 224nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251633(US9453031, 70)
Affinity DataIC50: 226nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251650(US9453031, 101)
Affinity DataIC50: 227nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251624(US9453031, 61)
Affinity DataIC50: 228nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251658(US9453031, 112)
Affinity DataIC50: 235nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251626(US9453031, 63)
Affinity DataIC50: 252nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251581(US9453031, 4)
Affinity DataIC50: 274nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251615(US9453031, 38)
Affinity DataIC50: 275nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251617(US9453031, 40)
Affinity DataIC50: 279nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251632(US9453031, 69)
Affinity DataIC50: 336nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251618(US9453031, 41)
Affinity DataIC50: 381nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251598(US9453031, 21)
Affinity DataIC50: 400nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#33-016), which is a homogeneous assay to me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251619(US9453031, 42)
Affinity DataIC50: 412nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251606(US9453031, 29)
Affinity DataIC50: 435nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251623(US9453031, 46)
Affinity DataIC50: 480nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#33-016), which is a homogeneous assay to me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251643(US9453031, 80)
Affinity DataIC50: 501nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251627(US9453031, 64)
Affinity DataIC50: 505nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251604(US9453031, 27)
Affinity DataIC50: 550nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251583(US9453031, 6)
Affinity DataIC50: 558nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251655(US9453031, 108)
Affinity DataIC50: 579nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251602(US9453031, 25)
Affinity DataIC50: 582nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251608(US9453031, 31)
Affinity DataIC50: 586nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251585(US9453031, 8)
Affinity DataIC50: 588nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251588(US9453031, 11)
Affinity DataIC50: 604nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251593(US9453031, 16)
Affinity DataIC50: 670nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#33-016), which is a homogeneous assay to me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251633(US9453031, 70)
Affinity DataIC50: 741nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#90-0083), which is a homogeneous assay to m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251605(US9453031, 28)
Affinity DataIC50: 785nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251611(US9453031, 34)
Affinity DataIC50: 808nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251635(US9453031, 72)
Affinity DataIC50: 820nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#33-016), which is a homogeneous assay to me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251592(US9453031, 15)
Affinity DataIC50: 851nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251593(US9453031, 16)
Affinity DataIC50: 852nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251629(US9453031, 66)
Affinity DataIC50: 854nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251633(US9453031, 70)
Affinity DataIC50: 870nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#33-016), which is a homogeneous assay to me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandPNGBDBM251622(US9453031, 45)
Affinity DataIC50: 886nMpH: 7.5 T: 2°CAssay Description:The kinase activity was measured by using the commercial ADP Hunter Plus assay available from DiscoveRx (#90-0083), which is a homogeneous assay to m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
Go to US Patent

Displayed 1 to 50 (of 272 total ) | Next | Last >>
Jump to: